Targeted disruption of RAR and RXR, mainly RARα and RXRα in the embryonic stage, resulted in early postnatal or embryonic lethality and heart failure [183,184], suggesting that RARα and RXRα are the two main receptor subtypes that are involved in the regulation of cardiomyocyte differentiation and function. This evidence concerns the gene RXRA and heart failure.